Similar articles for PMID: 21508407

Year	Number of Results
1994	1
1999	1
2000	2
2002	1
2003	1
2004	2
2005	3
2006	2
2007	9
2008	11
2009	11
2010	9
2011	9
2012	7
2013	7
2014	2
2015	4
2017	4
2019	3
2020	1
2021	1
2022	2
2024	1
2025	0

1

Phase II trial of preoperative chemotherapy for breast cancer: Japan Breast Cancer Research Network (JBCRN)-02 trial.

Iwase S, Yamamoto D, Kuroda Y, Kawaguchi T, Kitamura K, Odagiri H, Teramoto S, Akazawa K, Nagumo Y. Iwase S, et al. Anticancer Res. 2011 Apr;31(4):1483-7. Anticancer Res. 2011. PMID: 21508407 Clinical Trial.

2

Clinical significance of Ki-67 in neoadjuvant chemotherapy for primary breast cancer as a predictor for chemosensitivity and for prognosis.

Nishimura R, Osako T, Okumura Y, Hayashi M, Arima N. Nishimura R, et al. Breast Cancer. 2010 Oct;17(4):269-75. doi: 10.1007/s12282-009-0161-5. Breast Cancer. 2010. PMID: 19730975

3

Evaluation of changes of biologic markers ER, PR, HER 2 and Ki-67 in breast cancer with administration of neoadjuvant dose-dense doxorubicin, cyclophosphamide followed by paclitaxel.

Dede DS, Gumuskaya B, Guler G, Onat D, Altundag K, Ozisik Y. Dede DS, et al. J BUON. 2013 Jan-Mar;18(1):57-63. J BUON. 2013. PMID: 23613389 Free article.

4

A prognostic model based on combining estrogen receptor expression and Ki-67 value after neoadjuvant chemotherapy predicts clinical outcome in locally advanced breast cancer: extension and analysis of a previously reported cohort of patients.

Miglietta L, Morabito F, Provinciali N, Canobbio L, Meszaros P, Naso C, Murialdo R, Boitano M, Salvi S, Ferrarini M. Miglietta L, et al. Eur J Surg Oncol. 2013 Oct;39(10):1046-52. doi: 10.1016/j.ejso.2013.06.024. Epub 2013 Jul 26. Eur J Surg Oncol. 2013. PMID: 23890870

5

Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.

Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ. Lee KH, et al. BMC Cancer. 2007 Apr 12;7:63. doi: 10.1186/1471-2407-7-63. BMC Cancer. 2007. PMID: 17430582 Free PMC article.

6

Paclitaxel and carboplatin as neoadjuvant chemotherapy in patients with locally advanced breast cancer: A phase II Trial of the Hellenic Cooperative Oncology Group.

Gogas H, Pectasides D, Kostopoulos I, Lianos E, Skarlos D, Papaxoinis G, Bobos M, Kalofonos HP, Petraki K, Pavlakis K, Bafaloukos D, Fountzilas G. Gogas H, et al. Clin Breast Cancer. 2010 Jun;10(3):230-7. doi: 10.3816/CBC.2010.n.031. Clin Breast Cancer. 2010. PMID: 20497922 Clinical Trial.

7

Relationship between hormonal receptors, HER-2, p53 protein, Bcl-2, and MIB-1 status and the antitumor effects of neoadjuvant anthracycline-based chemotherapy in invasive breast cancer patients.

Kariya S, Ogawa Y, Nishioka A, Moriki T, Ohnishi T, Ito S, Murata Y, Yoshida S. Kariya S, et al. Radiat Med. 2005 May;23(3):189-94. Radiat Med. 2005. PMID: 15940066

8

Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel.

Torrisi R, Balduzzi A, Ghisini R, Rocca A, Bottiglieri L, Giovanardi F, Veronesi P, Luini A, Orlando L, Viale G, Goldhirsch A, Colleoni M. Torrisi R, et al. Cancer Chemother Pharmacol. 2008 Sep;62(4):667-72. doi: 10.1007/s00280-007-0652-z. Epub 2007 Dec 7. Cancer Chemother Pharmacol. 2008. PMID: 18064460 Clinical Trial.

9

Prognostic value of estrogen receptor and Ki-67 index after neoadjuvant chemotherapy in locally advanced breast cancer expressing high levels of proliferation at diagnosis.

Miglietta L, Vanella P, Canobbio L, Naso C, Cerisola N, Meszaros P, Parodi MA, Morabito F. Miglietta L, et al. Oncology. 2010;79(3-4):255-61. doi: 10.1159/000322189. Epub 2011 Mar 4. Oncology. 2010. PMID: 21372600

10

Evaluation of changes in biologic markers ER, PR, HER 2 and Ki-67 index in breast cancer with administration of neoadjuvant dose dense doxorubicin, cyclophosphamide followed by paclitaxel chemotherapy.

Dede DS, Gumuskaya B, Guler G, Onat D, Altundag K, Ozisik Y. Dede DS, et al. J BUON. 2013 Apr-Jun;18(2):366-71. J BUON. 2013. PMID: 23818347 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 21508407

83 results

Results by year